Physician profile
Kyle Frazier
NPI 1003102435
$2,211.57
in general payments reported to CMS, 2019-2025
12 companies · $469 in 2025
The $469 reported for 2025 was more than what 77% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $183 · 2021: $310 · 2022: $183 · 2023: $579 · 2024: $264 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $381.74 | 2023-2025 | Inspire |
| Axogen | $378.52 | 2019-2025 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Zimvie INC. | $307.64 | 2022-2025 | |
| Depuy Synthes Sales INC. | $292.23 | 2021-2025 | Matrixmandible, Trumatch, Matrixmidface |
| Kls-Martin L.P. | $226.89 | 2023-2025 | |
| Biohorizons Implant Systems INC. | $200.21 | 2020-2021 | |
| Stryker Corporation | $124.44 | 2019-2022 | |
| Medical Device Business Services, INC. | $109.83 | 2023-2024 | Trumatch |
| Zimmer Biomet Holdings, INC. | $86.17 | 2019-2020 | |
| Geistlich Pharma, North America, INC. | $55.46 | 2024 | Geistlich Bio-Gide |
| Ethicon US, LLC | $28.56 | 2024 | Monocryl |
| Novus Surgical Consultants | $19.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Frazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.